. Author manuscript; available in PMC: 2021 Sep 22.

Published in final edited form as: Transpl Infect Dis. 2021 Jul 16;23(4):e13682. doi: 10.1111/tid.13682

TABLE 2.

Odds ratio of possible end-organ disease

Unadjusted odds ratio of possible EO-CMV		95% CI	p-Value
TNF-α (pg/ml)	1.36	1.07–1.74	.01
IL-18 Log₂ (pg/ml)	8.35	1.58–44.08	.01
CMV Log₁₀ (IU/ml)	2.87	1.13–7.28	.03
IL-1β (0.1 pg/ml)	1.61	0.97–2.66	.06
IL-13 (pg/ml)	1.79	0.92–3.46	.09
IL-2 (pg/ml)	3.29	0.8–13.44	.10
IL-10 (pg/ml)	1.19	0.91–1.54	.20
IL-8 (pg/ml)	1.07	0.96–1.18	.22
IFN-g (pg/ml)	1.00	0.99–1.01	.53
IL-4 (pg/ml)	0.56	0.02–20.22	.75
IL-6 (pg/ml)	1.00	0.86–1.15	.97
IL-12p70 (pg/ml)	0.97	0.13–7.27	.97
Adjusted odds ratio of possible EO-CMV
IL-18 Log₂ (pg/ml)	6.97	1.19–40.84	.03
CMV Log₁₀ (IU/ml)	1.41	0.40–5.01	.54

Note: Unadjusted odds ratios and 95% CI were generated using a generalized linear model as described in materials and methods. Adjusted odds ratios and 95% CI were generated using a model containing both Log₂IL-18 and Log₁₀CMV.